Article
Prolonged duration of action of suxamethonium in pregnant and postpartum patients: A registry study.
Acta anaesthesiologica Scandinavica - 1 Jul 2024
Dalsten Helene, Crone Vera, Steinmetz Jacob, Rosager Christine L, Rasmussen Lars S, Vested Matias
Abstract excerpt
BACKGROUND: Suxamethonium is hydrolysed by butyrylcholinesterase (BChE) and a low BChE activity can result in a prolonged duration of action of suxamethonium. The BChE activity is reduced during pregnancy and postpartum period by up to 33%. However, it can also be reduced by mutations in the BChE gene. In this study, we assessed BChE activity and mutations in the BChE gene in pregnant and postpartum patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
